☰

Christopher R. Logg, Ph.D. - Publications

Affiliations: 
2002 University of Southern California, Los Angeles, CA, United States 
Area:
Molecular Biology, Genetics, Microbiology Biology, Oncology
Tree Info Similar researchers PubMed Report error

42 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Lin AH, Liu Y, Burrascano C, Cunanan K, Logg CR, Robbins JM, Kasahara N, Gruber H, Ibañez C, Jolly DJ. Extensive Replication of a Retroviral Replicating Vector Can Expand the A Bulge in the Encephalomyocarditis Virus Internal Ribosome Entry Site and Change Translation Efficiency of the Downstream Transgene. Human Gene Therapy Methods. PMID 26918465 DOI: 10.1089/Hgtb.2015.131  0.596
2015 Kubo S, Takagi-Kimura M, Logg CR, Hermann K, Kasahara N. 536. Dual-Vector Prodrug Activator Gene Therapy Using Retroviral Replicating Vectors Derived from Amphotropic Murine Leukemia Virus and Gibbon Ape Leukemia Virus Molecular Therapy. 23: S215. DOI: 10.1016/S1525-0016(16)34145-4  0.677
2015 Collins SA, Logg CR, Inagaki A, Kamijima S, Lehouritis P, Searle PF, Tangney M, Kasahara N. 433. Sequence-Optimized Nitroreductase for Retroviral Replicating Vector (RRV) Mediated Prodrug Activator Gene Therapy in Human Glioma Models Molecular Therapy. 23: S171. DOI: 10.1016/S1525-0016(16)34042-4  0.703
2014 Burnett R, Ibañez CE, Pettersson PL, Chen CI, Parab S, Huang T, Robbins J, Bankiewicz K, Aghi M, Logg C, Kasahara N, Pertschuk D, Gruber HE, Jolly DJ. Maintaining therapeutic activity in the operating room: compatibility of a gamma-retroviral replicating vector with clinical materials and biofluids. Molecular Therapy. Methods & Clinical Development. 1: 14024. PMID 26015967 DOI: 10.1038/Mtm.2014.24  0.556
2014 Lin AH, Timberlake N, Logg CR, Liu Y, Kamijima S, Diago O, Wong K, Gammon DK, Ostertag D, Hacke K, Yang EC, Gruber H, Kasahara N, Jolly DJ. MicroRNA 142-3p attenuates spread of replicating retroviral vector in hematopoietic lineage-derived cells while maintaining an antiviral immune response. Human Gene Therapy. 25: 759-71. PMID 24825189 DOI: 10.1089/Hum.2012.216  0.655
2014 Collins S, Logg C, Inagaki A, Kamijima S, Lehouritis P, Searle P, Tangney M, Kasahara N. ET-13 * RETROVIRAL REPLICATING VECTOR (RRV)-MEDIATED PRODRUG ACTIVATOR GENE THERAPY WITH CODON-OPTIMIZED NITROREDUCTASE IN EXPERIMENTAL GLIOMA Neuro-Oncology. 16: v81-v82. DOI: 10.1093/Neuonc/Nou255.13  0.705
2013 Perez OD, Logg CR, Hiraoka K, Diago O, Burnett R, Inagaki A, Jolson D, Amundson K, Buckley T, Lohse D, Lin A, Burrascano C, Ibanez C, Kasahara N, Gruber HE, et al. Erratum: Design and selection of toca 511 for clinical use: Modified retroviral replicating vector with improved stability and gene expression (Molecular Therapy (2012) 20 (1689-1698) DOI:10.1038/mt.2012.83) Molecular Therapy. 21. PMID 28160846 DOI: 10.1038/Mt.2013.6  0.598
2013 Lemp NA, Haga K, Hacke K, Treger JA, Bogan BT, Faure-Kumar E, Logg CR, Kruse CA, Cicciarelli JC, Kasahara N. Reduction of HLA class I expression by ribonucleic acid interference mitigates allogenicity of human primary and Immortalized cells. Clinical Transplants. 93-101. PMID 25095496  0.51
2013 Kubo S, Takagi-Kimura M, Logg CR, Kasahara N. Highly efficient tumor transduction and antitumor efficacy in experimental human malignant mesothelioma using replicating gibbon ape leukemia virus. Cancer Gene Therapy. 20: 671-7. PMID 24201868 DOI: 10.1038/Cgt.2013.67  0.696
2013 KAMIJIMA S, KIMURA T, HAGA K, HIRAOKA K, INAGAKI A, LOGG C, KAO C, BOCHNER B, KASAHARA N. 328 PROSTATE-TARGETED RETROVIRAL REPLICATING VECTORS FOR PRODRUG-ACTIVATOR GENE THERAPY Journal of Urology. 189. DOI: 10.1016/J.Juro.2013.02.1713  0.597
2012 Lemp NA, Hiraoka K, Kasahara N, Logg CR. Cryptic transcripts from a ubiquitous plasmid origin of replication confound tests for cis-regulatory function. Nucleic Acids Research. 40: 7280-90. PMID 22618870 DOI: 10.1093/Nar/Gks451  0.531
2012 Perez OD, Logg CR, Hiraoka K, Diago O, Burnett R, Inagaki A, Jolson D, Amundson K, Buckley T, Lohse D, Lin A, Burrascano C, Ibanez C, Kasahara N, Gruber HE, et al. Design and selection of Toca 511 for clinical use: modified retroviral replicating vector with improved stability and gene expression. Molecular Therapy : the Journal of the American Society of Gene Therapy. 20: 1689-98. PMID 22547150 DOI: 10.1038/Mt.2012.83  0.639
2012 Logg CR, Robbins JM, Jolly DJ, Gruber HE, Kasahara N. Retroviral replicating vectors in cancer. Methods in Enzymology. 507: 199-228. PMID 22365776 DOI: 10.1016/B978-0-12-386509-0.00011-9  0.677
2011 Hiraoka K, Inagaki A, Logg CR, Kamijima S, Hui KM, Marini FC, Kasahara N. Abstract 5397: Human mesenchymal stem cell-based cell carrier for tumor-homing delivery of replicating retrovirus vectors in glioblastoma models Cancer Research. 71: 5397-5397. DOI: 10.1158/1538-7445.Am2011-5397  0.603
2011 Kamijima S, Kimura T, Haga K, Hiraoka K, Inagaki A, Logg CR, Kao C, Bochner BH, Ichikawa T, Kasahara N. Abstract 5393: Prodrug activator gene therapy mediated by prostate-specific replicating retrovirus vectors Cancer Research. 71: 5393-5393. DOI: 10.1158/1538-7445.Am2011-5393  0.66
2011 Inagaki A, Hiraoka K, Logg CR, Kamijima S, Ostertag D, Perez OD, Gruber HE, Jolly DJ, Robbins JM, Kasahara N. Abstract 5386: Therapeutic efficacy of RMLV vectors in human and murine glioma models Cancer Research. 71: 5386-5386. DOI: 10.1158/1538-7445.Am2011-5386  0.72
2010 Kimura T, Hiraoka K, Kasahara N, Logg CR. Optimization of enzyme-substrate pairing for bioluminescence imaging of gene transfer using Renilla and Gaussia luciferases. The Journal of Gene Medicine. 12: 528-37. PMID 20527045 DOI: 10.1002/Jgm.1463  0.558
2010 Tai CK, Wang W, Lai YH, Logg CR, Parker WB, Li YF, Hong JS, Sorscher EJ, Chen TC, Kasahara N. Enhanced efficiency of prodrug activation therapy by tumor-selective replicating retrovirus vectors armed with the Escherichia coli purine nucleoside phosphorylase gene. Cancer Gene Therapy. 17: 614-23. PMID 20467451 DOI: 10.1038/Cgt.2010.17  0.768
2009 Haga K, Tomioka A, Liao CP, Kimura T, Matsumoto H, Ohno I, Hermann K, Logg CR, Jiao J, Tanaka M, Hirao Y, Wu H, Kruse CA, Roy-Burman P, Kasahara N. PTEN knockout prostate cancer as a model for experimental immunotherapy. The Journal of Urology. 181: 354-62. PMID 19010487 DOI: 10.1016/J.Juro.2008.08.124  0.56
2008 Baranick BT, Lemp NA, Nagashima J, Hiraoka K, Kasahara N, Logg CR. Splicing mediates the activity of four putative cellular internal ribosome entry sites. Proceedings of the National Academy of Sciences of the United States of America. 105: 4733-8. PMID 18326627 DOI: 10.1073/Pnas.0710650105  0.49
2008 Haga K, Tomioka A, Kimura T, Liao C, Matsumoto H, Ohno I, Logg CR, Hermann KJ, Tanaka M, Uemura H, Hirao Y, Roy-Burman P, Kasahara N. SUICIDE GENE THERAPY USING REPLICATION-COMPETENT RETROVIRUS (RCR) COMBINED WITH TUMOR-SPECIFIC CYTOTOXIC T LYMPHOCYTES (CTLs) FOR PTEN KNOCK-OUT SPONTANEOUS PROSTATE CANCER MODEL Journal of Urology. 179: 41-42. DOI: 10.1016/S0022-5347(08)60126-3  0.605
2007 Kikuchi E, Menendez S, Ozu C, Ohori M, Cordon-Cardo C, Logg CR, Kasahara N, Bochner BH. Highly efficient gene delivery for bladder cancers by intravesically administered replication-competent retroviral vectors. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 4511-8. PMID 17671137 DOI: 10.1016/J.Juro.2007.10.016  0.677
2007 Hiraoka K, Kimura T, Logg CR, Tai CK, Haga K, Lawson GW, Kasahara N. Therapeutic efficacy of replication-competent retrovirus vector-mediated suicide gene therapy in a multifocal colorectal cancer metastasis model. Cancer Research. 67: 5345-53. PMID 17545615 DOI: 10.1158/0008-5472.Can-06-4673  0.756
2007 Logg CR, Baranick BT, Lemp NA, Kasahara N. Adaptive evolution of a tagged chimeric gammaretrovirus: identification of novel cis-acting elements that modulate splicing. Journal of Molecular Biology. 369: 1214-29. PMID 17498744 DOI: 10.1016/J.Jmb.2007.04.026  0.617
2007 Kikuchi E, Menendez S, Ozu C, Ohori M, Cordon-Cardo C, Logg CR, Kasahara N, Bochner BH. Delivery of replication-competent retrovirus expressing Escherichia coli purine nucleoside phosphorylase increases the metabolism of the prodrug, fludarabine phosphate and suppresses the growth of bladder tumor xenografts. Cancer Gene Therapy. 14: 279-86. PMID 17218950 DOI: 10.1038/Sj.Cgt.7701013  0.7
2007 Haga K, Lemp NA, Logg CR, Nagashima J, Faure-Kumar E, Gomez GG, Mendez R, Stripecke R, Kruse CA, Cicciarelli JC, Kasahara N. 1911: HLA Class I Silencing by Lentiviral Vector-Mediated Shrna Delivery Averts Cytotoxicity by Alloreactive T Lymphocytes Journal of Urology. 177: 634-635. DOI: 10.1016/S0022-5347(18)32084-6  0.529
2006 Haga K, Lemp NA, Logg CR, Nagashima J, Faure-Kumar E, Gomez GG, Kruse CA, Mendez R, Stripecke R, Kasahara N, Kasahara NA, Cicciarelli JC. Permanent, lowered HLA class I expression using lentivirus vectors with shRNA constructs: Averting cytotoxicity by alloreactive T lymphocytes. Transplantation Proceedings. 38: 3184-8. PMID 17175217 DOI: 10.1016/j.transproceed.2006.10.158  0.514
2006 Hiraoka K, Kimura T, Logg CR, Kasahara N. Tumor-selective gene expression in a hepatic metastasis model after locoregional delivery of a replication-competent retrovirus vector. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 12: 7108-16. PMID 17145835 DOI: 10.1158/1078-0432.Ccr-06-1452  0.691
2005 Dalba C, Klatzmann D, Logg CR, Kasahara N. Beyond oncolytic virotherapy: replication-competent retrovirus vectors for selective and stable transduction of tumors. Current Gene Therapy. 5: 655-67. PMID 16457654 DOI: 10.2174/156652305774964659  0.717
2005 Kikuchi E, Menendez S, Ozu C, Ohori M, Cordon-Cardo C, Logg CR, Kasahara N, Bochner BH. 783: Suppression of Bladder Cancer Growth by a Replication-Competent Retroviral Transfer of Escherichia Coli Purine Nucleoside Phosphorylase and Fludarabine Phosphate in Nude Mice Journal of Urology. 173: 212-212. DOI: 10.1016/S0022-5347(18)34952-8  0.539
2005 Hiraoka K, Kimura T, Logg C, Kondo S, Kasahara N. 834. Highly Efficient and Tumor-Selective Gene Delivery in Metastatic Colon Cancer Models Using a Replication-Competent Retrovirus Vector Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.07.377  0.602
2005 Ozu C, Kikuchi E, Menendez S, Cardo CC, Logg CR, Kasahara N, Bochner BH. 710. Tissue-Specific Gene Therapy by Replication-Competent Retroviral Vector for Prostate Cancer with Fludarabine Phosphate Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.07.250  0.632
2004 Logg CR, Kasahara N. Retrovirus-mediated gene transfer to tumors: utilizing the replicative power of viruses to achieve highly efficient tumor transduction in vivo. Methods in Molecular Biology (Clifton, N.J.). 246: 499-525. PMID 14970613 DOI: 10.1385/1-59259-650-9:499  0.702
2004 Kikuchi E, Menendez S, Ohori M, Cardon-Carda C, Logg CR, Kasahara N, Bochner BH. 962: Highly Efficient Therapeutic Gene Delivery for Bladder Cancers by Intravesically Administered Replication-Competent Retroviral Vectors Journal of Urology. 171: 255-255. DOI: 10.1016/S0022-5347(18)38199-0  0.65
2003 Tai CK, Logg CR, Park JM, Anderson WF, Press MF, Kasahara N. Antibody-mediated targeting of replication-competent retroviral vectors. Human Gene Therapy. 14: 789-802. PMID 12804141 DOI: 10.1089/104303403765255174  0.731
2002 Logg CR, Logg A, Matusik RJ, Bochner BH, Kasahara N. Tissue-specific transcriptional targeting of a replication-competent retroviral vector. Journal of Virology. 76: 12783-91. PMID 12438603 DOI: 10.1128/Jvi.76.24.12783-12791.2002  0.703
2002 Soifer H, Higo C, Logg CR, Jih LJ, Shichinohe T, Harboe-Schmidt E, Mitani K, Kasahara N. A novel, helper-dependent, adenovirus-retrovirus hybrid vector: stable transduction by a two-stage mechanism. Molecular Therapy : the Journal of the American Society of Gene Therapy. 5: 599-608. PMID 11991751 DOI: 10.1006/Mthe.2002.0586  0.77
2002 Soiefer H, Higo C, Logg CR, Jih LJL, Shichinohe T, Harboe-Schmidt E, Mitani K, Kasahara N. A Novel, Helper-Dependent, Adenovirus–Retrovirus Hybrid Vector: Stable Transduction by a Two-Stage Mechanism: MOLECULAR THERAPY 5: 599–608 (2002). doi:10.1006/mthe.2001.0586 Molecular Therapy. 6. DOI: 10.1006/Mthe.2002.0641  0.537
2001 Chang Z, Pan J, Logg C, Kasahara N, Roy-Burman P. A replication-competent feline leukemia virus, subgroup A (FeLV-A), tagged with green fluorescent protein reporter exhibits in vitro biological properties similar to those of the parental FeLV-A. Journal of Virology. 75: 8837-41. PMID 11507228 DOI: 10.1128/Jvi.75.18.8837-8841.2001  0.643
2001 Logg CR, Logg A, Tai CK, Cannon PM, Kasahara N. Genomic stability of murine leukemia viruses containing insertions at the Env-3' untranslated region boundary. Journal of Virology. 75: 6989-98. PMID 11435579 DOI: 10.1128/Jvi.75.15.6989-6998.2001  0.692
2001 Logg CR, Tai CK, Logg A, Anderson WF, Kasahara N. A uniquely stable replication-competent retrovirus vector achieves efficient gene delivery in vitro and in solid tumors. Human Gene Therapy. 12: 921-32. PMID 11387057 DOI: 10.1089/104303401750195881  0.778
2000 Smith E, Redman RA, Logg CR, Coetzee GA, Kasahara N, Frenkel B. Glucocorticoids inhibit developmental stage-specific osteoblast cell cycle. Dissociation of cyclin A-cyclin-dependent kinase 2 from E2F4-p130 complexes. The Journal of Biological Chemistry. 275: 19992-20001. PMID 10867026 DOI: 10.1074/Jbc.M001758200  0.5
Show low-probability matches.